Metabolism: They slow gastric emptying (making you feel full longer) and can improve heart and liver health markers
While GLP-1 analogues like semaglutide (Wegovy), liraglutide (Ozempic), oral semaglutide (Rybelsus), retatrutide, and tirzepatide have shown significant efficacy as standalone treatments for weight management, combining these medications with other weight loss therapies may lead to even more substantial results
Main Retatrutide hub: /retatrutide
Retatrutide is an investigational triple agonist targeting GLP-1, GIP, and glucagon receptors simultaneously, but it remains unlicensed in the UK and is only available within regulated clinical trials
What Comes Next Duodenal mucosal resurfacing is still considered investigational
Limited food cravings lead to the ingestion of smaller portions and a better control of eating habits